BibTex format
@inproceedings{Tutt:2017:10.1158/1538-7445.SABCS16-S6-01,
author = {Tutt, A and Cheang, MCU and Kilburn, L and Tovey, H and Gillett, C and Pinder, S and Lanchbury, J and Abraham, J and Barrett, S and Barrett-Lee, P and Chan, S and Gazinska, P and Grigoriadis, A and Kernaghan, S and Hoadley, K and Gutin, A and Harper-Wynne, C and Hatton, M and Owen, J and Parker, P and Roylance, R and Shaw, A and Smith, I and Thompson, R and Timms, K and Wardley, A and Wilson, G and Harries, M and Ellis, P and Ashworth, A and Perou, C and Bliss, J and Rahman, N and Brown, R},
doi = {10.1158/1538-7445.SABCS16-S6-01},
publisher = {AMER ASSOC CANCER RESEARCH},
title = {BRCA1 methylation status, silencing and treatment effect in the TNT trial: A randomized phase III trial of carboplatin compared with docetaxel for patients with metastatic or recurrent locally advanced triple negative or BRCA1/2 breast cancer (CRUK/07/012)},
url = {http://dx.doi.org/10.1158/1538-7445.SABCS16-S6-01},
year = {2017}
}